Kolexia
Laude Marie-Charlotte Hématologie
Laude Marie-Charlotte
Hématologie
Centre Léon-Bérard
Lyon, France
40 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Lymphome B Aberrations des chromosomes Gammapathie monoclonale de signification indéterminée Myélome multiple Hémopathies

Collaborateurs

Voir plus
Michallet Anne-Sophie
Michallet Anne-Sophie
Centre Léon-Bérard, Lyon, France
Golfier Camille
Golfier Camille
Hôpital Lyon Sud, Pierre-Bénite, France
Lebras Laure
Lebras Laure
Centre Léon-Bérard, Lyon, France
Noel Robin
Noel Robin
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
Amgen
3 collaboration(s)
Dernière en 2023
Janssen
3 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
2 collaboration(s)
Dernière en 2023
EXAFIELD
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
A Genomic Approach for High-Grade B Cell Lymphoma with MYC and BCL2 and / or BCL6 Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results
65th ASH Annual Meeting Abstracts   02 novembre 2023
Clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France.
Cancer medicine   07 août 2023
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans.
Current research in translational medicine   04 février 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
American journal of hematology   01 janvier 2023
A Genomic Approach in High-Grade B Cell Lymphoma with MYC and BCL2 and / or BCL6 Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results
Annual Meeting Abstracts 2022   15 novembre 2022
Production préclinique de CART cells IL-1RAP “GMP-like” en vue d’un essai Clinique de phase Ib.–Expérience bisontine
Livre des résumés - XXXe Congrès de la Société Française de Transfusion Sanguine (SFTS) - Marseille, 24-26 novembre 2021   01 novembre 2021
First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study.
American journal of hematology   29 décembre 2020
Retrospective Evaluation of Rituximab, Methotrexate, Procabazine, Vincristine and Etoposide Followed By Consolidation with Rituximab, Aracytine and Ifosfamide for Elderly Patients with Newly Diagnosed Primary CNS Lymphoma
Blood   05 novembre 2020
Diagnosis-to-Treatment Interval Is an Important Prognostic Factor with a Time-Dependent Effect Predicting Event-Free Survival after 12 Months from First-Line Treatment in Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma
Blood   05 novembre 2020
Giant Blisters.
Journal of stomatology, oral and maxillofacial surgery   18 janvier 2019